Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Capsules
Reexamination Certificate
2005-05-10
2005-05-10
Page, Thurman K. (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Capsules
C424S451000
Reexamination Certificate
active
06890558
ABSTRACT:
The invention described herein relates to a pharmaceutical composition containing vinorelbine as an active ingredient which is suitable for encapsulation in soft capsules. The liquid oral pharmaceutical composition suitable for a liquid fill composition for a soft capsule dosage form comprises: vinorelbine or a pharmaceutically acceptable salt thereof; ethanol; water; glycerol; and polyethylene glycol. In a preferred embodiment, the tartrate salt form of vinorelbine is used in the composition. The invention also provides for a method of treating cancer comprising orally administering, to a patient in need of treatment thereof, a soft capsule comprising the pharmaceutical composition of the invention.
REFERENCES:
patent: 4623629 (1986-11-01), Kerschensteiner
patent: 5114919 (1992-05-01), Baldwin et al.
patent: 5292512 (1994-03-01), Schaefer et al.
patent: 5620985 (1997-04-01), Jacquesy et al.
patent: 5645856 (1997-07-01), Lacy et al.
patent: 6127377 (2000-10-01), Duflos et al.
patent: 6197760 (2001-03-01), Struck
patent: 6235761 (2001-05-01), Hartman et al.
patent: 6262093 (2001-07-01), Camden
patent: 6310039 (2001-10-01), Kratz
patent: 375520 (1993-04-01), None
patent: 010 458 (1998-04-01), None
Zhou et al, Relative Bioavailability of Two Oral Formulations of Navelbine in Cancer Patients, 1994, Biopharmaceutical & Drug Disposition, vol. 12, 577-586.*
Zhou et al, Relative Bioavailability of Two Oral Formulations of Navelbine in Cancer Patients, 1994, Biopharmaceutics & Drug Disposition, vol. 12, 577-586.*
Rowinsky et al., “Pharmacokinetic, Bioavailability, and Feasibility Study of Oral Vinorelbine in Patients with Solid Tumors,”J. Clin. Oncol., vol. 12 (9) (Sep. 1994), pp. 1754-1763.
Zhou et al., “Relative Bioavailability of Two Oral Formulations of Navelbine in Cancer Patients.”Biopharmaceutics&Drug Disposition, vol. 15 (1994). pp. 577-586; and.
Jassem et al.. “A Multicenter Randomized Phase II Study of Oral vs. Intravenous Vinorelbine in Advanced Non-small-cell Lung Cancer Patients.”Annals of Oncology, vol. 12 (2001) p. 1375-1381.
Bohn Marie-Madeleine
Bougaret Joel
Heintz Norbert
Leverd Elie
Nickey Donald O.
Page Thurman K.
R.P. Scherer Technologies, Inc.
Rozycki Andrew G.
Young Micah-Paul
LandOfFree
Oral pharmaceutical composition for soft capsules containing... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oral pharmaceutical composition for soft capsules containing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oral pharmaceutical composition for soft capsules containing... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3437380